Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: Importance in ARDS in septic pediatric critically ill patients

Human Immunology

Volumn 73, Issue 6, 2012, Pages 661-667

  Azevedo, Z M ^a   Moore, D B ^a   Lima, F C ^a   Cardoso, C C ^a   Bougleux, R ^a   Matos, G I ^a   Luz, R A ^a   Xavier Elsas, P ^b   Sampaio, E P ^a   Gaspar Elsas, M I ^a   Moraes, M O ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acute respiratory distress syndrome; Children; Genetic polymorphism; Lymphotoxin alpha; Sepsis; Tumor necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLELE; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; INFECTION SENSITIVITY; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ALLELES; BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LYMPHOTOXIN-ALPHA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK; SEPSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861762389     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.03.007     Document Type: Article

References (58)

1. Stoll B.J., Holman R.C., Schuchat A. Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics 1998, 102:e18.
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinski M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cost of care. Crit Care Med 2001, 29:1303-1310.
3. Goldstein B., Giroir B., Randolph A. International pediatric sepsis consensus conference. Definitions for sepsis and organ dysfunction in pediatrics. Pediatr CritCare Med 2005, 6:2-8.
4. Tan J.H., Temple S.E., Kee C., Waterer G.W., Tan C.R., Gut I., Price P. Characterisation of TNF block haplotypes affecting the production of TNF and LTA. Tissue Antigens 2010, 77:100-106.
5. Cardoso C.C., Pereira A.C., De Sales Marques C., Moraes M.O. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol 2011, 6:533-549.
6. Teuffel O., Ethier M.C., Beyene J., Sung L. Association between tumor necrosis factor-α promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis. Crit Care Med 2009, 38:276-282.
7. Tiancha H., Huiqin W., Jyiong J., et al. Association between lymphotoxin-a intron +252 polymorphism, and sepsis: A meta-analysis. Scand J Infec Dis 2011.
8. Chauhan M., Mc Guire W. Interleukin-6 (-174C) polymorphism and the risk of sepsis in very low birth weight infants: meta-analysis. Arch Dis Child Fetal Neonatal 2008, 93:427-429.
9. Lei M.G., Gao J.J., Morrison D.C., Qureshi N. Pathogenesis of sepsis: current concepts and emerging therapies. Mo Med 2003, 100(5):524-529.
10. Villar J. Genetics and the pathogenesis of adult respiratory distress syndrome. CurrOp Crit Care 2002, 8:1-5.
11. Marshall J.C.E., Reinhart K. Biomarkers of sepsis. Crit Care Med 2009, 37:2290-2298.
12. Pappachan J.V., Coulson T.G., Child N.J., Markham D.J.N.S.M., Pulletz M., Rose-Zerilli M.J., Courcey-Golder K., Barton S.J., Yang I.A., Holloway J.W. Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF-238A polymorphism. Immunogenetics 2009, 61:657-662.
13. Waterer G.W., Quasney M.W., Cantor R.M., Wunderink R.G. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001, 163:1599-1604.
14. Garnacho-Montero J., Aldabo-Pallas T., Garnacho-Montero C., Cayuela A., Jiménez R., Barroso S., Ortiz-Leyba C. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 2006, 10:R111.
15. Gu W., Zeng L., Zhou J., Jiang D.P., Zhang L., Du D.Y., Hu P., Chen K., Liu Q., Wang Z.G., Jiang J.X. Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients. Intensive Care Med 2010, 36:1261-1265.
16. Watanabe E., Buchman T.G., Hirasawa H., Zehnbauer B.A. Association between lymphotoxin α (tumor necrosis factor β) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med 2010, 38:181-193.
17. Solé-Violán J., de Castro F., García-Laorden M.I., Blanquer J., Aspa J., Borderías L., Briones M.L., Rajas O., Carrondo I.M., Marcos-Ramos J.A., FerrerAgüero J.M., Garcia-Saavedra A., Fiuza M.D., Caballero-Hidalgo A., Rodriguez-Gallego C. Genetic variability in the severity and outcome of community-acquired pneumonia. Respir Med 2010, 104:440-447.
18. Carregaro F., Carta A., Cordeiro J.A., Lobo S.M., Silva E.H., Leopoldino A.M. Polymorphisms IL10-819 and TLR-2 are potentially associated with sepsis in Brazilian patients. Mem Inst Oswaldo Cruz 2010, 105:649-656.
19. Paskulin D.D., Fallavena P.R., Paludo F.J., Borges T.J., Picanço J.B., Dias F.S., Alho C.S. TNF-308G > A promoter polymorphism (rs1800629) and outcome from critical illness. Braz J Infect Dis 2011, 15(3):231-238.
20. Cornell T.T., Wynn J., Shanley T.P., Wheeler D.S., Wong H.R. Mechanisms and regulation of the gene expression response to sepsis. Pediatrics 2010, 125:1248-1258.
21. Härtel C., Hemmelmann C., Faust K., Gebauer C., Hoehn T., Kribs A., Laux R., Nikischin W., Segerer H., Teig N., von der Wense A., Wieg C., Herting E. For the German Neonatal Network. Tumor necrosis factor-α promoter -308 G/A polymorphism and susceptibility to sepsis in very-low-birth-weight infants. Crit Care Med 2011, 68:323-329.
22. Abu-Maziad A., Schaa K., Bell E.F., Dagle J.M., Cooper M., Marazita M.L., Murray J.C. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 2010, 68:323-329.
23. Aneja R.J., Carcillo J.A. Differences between pediatric and adult septic shock. Minerva Anestesiol 2011, 77:1-2.
24. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., Lamy M., Legall J.R., Morris A., Spragg R. The American European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
25. Shann F., Pearson G., Slater A., Wilkinson K. Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intens Care Med 1997, 23:201-207.
26. Pollack M.M., Ruttimann U.E., Getson P.R. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988, 16:1110-1116.
27. IBGE; 2009 http://www.ibge.gov.br.
28. Cardoso C.C., Pereira A.C., Brito-de-Souza V.N., Dias-Baptista I.M., Maniero V.C., Venturini J., Vilani-Moreno F.R., de Souza F.C., Ribeiro-Alves M., Sarno E.N., Pacheco A.G., Moraes M.O. IFNG+874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Human Genet 2010, 128:481-490.
29. Santos A.R., Suffys P.N., Vanderborght P.R., Moraes M.O., Vieira L.M., Cabello P.H., Bakker A.M., Matos H.J., Huizinga T.W., Ottenhoff T.H., Sampaio E.P., Sarno E.N. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 2002, 186:1687-1691.
30. Wennberg P., Nordström P., Lorentzon R., Lerner U.H., Lorentzon M. TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol. 2002, 146:629-634.
31. Pacheco A.G., Moraes M.O. Genetic polymorphisms of infectious diseases in case control studies. Dis Markers 2009, 26:1-14.
32. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2008.
33. Ettinger R., Mebius R., Browning J.L., Michie S.A., Tuijl S.V., Kraal G., Ewijk W.V., McDevitt H.O. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development. Int Immunol 1998, 5:727-741.
34. Tumanov A.V., Grivennikov S.I., Kruglov A.A., Shebzukhov Y.V., Koroleva E.P., Piao Y., et al. Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs. Blood 2010, 116:3456-3464.
35. Jarvela I., Torniainen S., Kolho K.L. Molecular genetics of human lactase deficiency. Ann Med 2009, 41:568-575.
36. Mattar R., Monteiro M.S., Kinoshita J.M., Carrilho F.J. LCT-22018G>A single nucleotide polymorphism is a better predictor of adult-type hypolactasia/lactase persistence in Japanese-Brazilians than LCT-13910C>T. Clinics 2010, 65(12):1399-1400.
37. Alcaïs A., Alter A., Antoni G., Orlova M., Nguyen V.T., Singh M., Vanderborght P.R., Katoch K., Mira M.T., Vu H.T., Ngyuen T.H., Nguyen N.B., Moraes M., Mehra N., Schurr E., Abel L. Stepwise replication identifies a low producing lymphotoxin alpha allele as a major risk factor for early onset leprosy. Nat Genet 2007, 4:517-522.
38. Alcaïs A., Fieschi C., Abel L., Casanova J.L. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 2005, 19:1617-1621.
39. Gong M., Zhou W., Williams P., Thompson B., Pothier L., Boyce P., Christiani D. 308GA and TNFB polymorphism in acute respiratory distress syndrome. Eur Respir J 2005, 26:382-389.
40. Lin W.C., Lin C.F., Chen C.L., Chen C.W., Lin Y.S. Prediction of outcome in patients with acute respiratory distress syndrome by brochoalveolar lavage inflammatory mediators. Exp Biol Med 2010, 235:57-65.
41. Chetan G., Rathisharmila P., Narayanan P., Mahadevan S. Acute respiratory distress syndrome in pediatric intensive care unit. Indian J Pediatr 2009, 76:1013-1016.
42. Galani V., Tatsaki E., Bai M., Kitsoulis P., Lekka M., Nakos G., Kanavaros P. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): An up-to-date cell-specific review. Pathol Res Pract 2010, 206:145-150.
43. Kurahashi K., Kajikawa O., Sawa T., Ohara M., Gropper M.A., Frank D.W., Martin T.R., Wiener-Kronish J.P. Pathogenesis of septic shock in pseudomonas aeruginosa pneumonia. J Clin Invest 1999, 104:743-750.
44. Nadel S., Newport M.J., Booy R., Levin M. Variation in the tumor necrosis factor-a gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996, 174:878-880.
45. Yu B.J., Li J.S., Zhang D.L., Tang X.M. The associations of the single nucleotide polymorphisms on TNF and CD14 promoters with the mortality of infection, systematic inflammatory response syndrome and sepsis in surgical patients. Zhonghya Yi Xue Za Zhi 2003, 83:2132-2136.
46. Shimada T., Oda S., Sadahiro T., Nakamura M., Hirayama Y., Watanabe E., Abe R., Nakada T.A., Tateishi Y., Otani S., Hirasawa H., Tokuhisa T., Uno H. Outcome prediction in sepsis combined use of genetic polymorphisms - a study in Japanese population. Cytokine 2011, 54:79-84.
47. Surbatovic M., Grujic K., Cikota B., Jevtic M., Filipovic N., Romic P., Strelic N., Magic Z. Polymorphisms of genes encoding tumor necrosis factor-alpha, interleukin-10, cluster of differentiation-14 and interleukin-1ra in critically ill patients. J Crit Care 2010, 25:542-548.
48. Pereira A.C., Brito-de-Souza V.N., Cardoso C.C., Dias-Baptista I.M., Parelli F.P., Venturini J., villain-Moreno F.R., Pacheco A.G., Moraes M.O. Genetic, epidemiological and biological analysis of interleukin 10 promoter single nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun 2009, 10:174-180.
49. Matos G.I., Covas C.D.E.J., Bittar R.C., Gomes-Silva A., Marques F., Maniero V.C., Amato V.S., Oliveira-Neto M.P., Mattos M.D.A., Pirmez C., Sampaio E.P., Moraes M.O., DA-Cruz A.M. IFNG+874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production. BMC Infect Dis 2007, 7:33.
50. Gallagher G, Moraes MO, Anaya JM. Tumor necrosis factor and related genes. In: RK, editor. Genetic susceptibility to infectious diseases, vol. 1. Oxford, New York: 1a ed. Oxford University Press; 2007. p. 190-207.
51. Arsene Mekinian A., Tamouza R., Pavy S., Gestermann N., Ittah M., MarietteXMiceli-Richard C. Functional study of TNF- promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 2011, 22:88-102.
52. Tobin D.M., Roca F.J., Oh S.F., McFarland R., Vickery T.W., Ray J.P., Ko D.C., Zou Y., Bang N.D., Chau T.T., Vary J.C., Hawn T.R., Dunstan S.J., Farrar J.F., Thwaites G.E., King M.C. Host genotype-specific therapies can optimize the inflammatory response to Mycobacterial infections. Cell 2012, 148:434-446.
53. Menges T., König I.R., Hossain H., Little S., Tchatalbachev S., Thierer F., Hackstein H., Franjkovic I., Colaris T., MartensFweismuller K., Langefeld T., Stricker J., Hempelmann N.G., Vos P.E., Ziegler A., Jacobs B., chakraborty T., Bein G. Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor. Crit Care Med 2008, 36:1456-1462.
54. Karimi M., Goldie L.C., Cruickshank M.N., Moses E.K., Abraham L.J. A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 2009, 17:1454-1462.
55. Skoog T., Hamsten A., Eriksson P. Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter. Biochem Biophys Res Commun 2006, 22(351):777-783.
56. Skoog T., van't Hooft F.M., Kallin B., Jovinge S., Boquist S., Nilsson J., Eriksson P., Hamsten A. A common functional polymorphism (C - - > A substitution at position - 863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999, 8:1443-1449.
57. Allen R.D. Polymorphism of the human TNF-a promoter: random variation or functional diversity?. Mol Immunol 1999, 36:1017-1027.
58. Majetschak M., Obertacke U., Schade F.U., Bardenheuer M., Voggenreiter G., Bloemeke B., Hessen M. Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients. Clin Diagn Lab Immunol 2002, 1205-1211.